Enzalutamide in Prostate Cancer after Chemotherapy

被引：5
|
作者：
Berruti, Alfredo [1 ]
Generali, Daniele [2 ]
Tampellini, Marco [3 ]
机构：
[1] Univ Brescia, Brescia, Italy
[2] Istituti Ospitalieri, Cremona, Italy
[3] Univ Turin, Orbassano, Italy
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 367卷 / 25期
关键词：
INCREASED SURVIVAL; MIGRAINE;
D O I：
10.1056/NEJMc1212940
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2448 / 2448
页数：1
相关论文
共 50 条
  • [31] Emerging mechanisms of enzalutamide resistance in prostate cancer
    Claessens, Frank
    Helsen, Christine
    Prekovic, Stefan
    Van den Broeck, Thomas
    Spans, Lien
    Van Poppel, Hendrik
    Joniau, Steven
    NATURE REVIEWS UROLOGY, 2014, 11 (12) : 712 - 716
  • [32] MCT INHIBITION RESENSITIZES ENZALUTAMIDE-RESISTANT PROSTATE CANCER CELLS TO ENZALUTAMIDE
    Bhattacharjee, Sayani
    Wynn, Rebecca
    Sindhwani, Puneet
    Petros, Firas
    Nadiminty, Nagalakshmi
    JOURNAL OF UROLOGY, 2023, 209 : E146 - E146
  • [33] Enzalutamide in Castration-Resistant Prostate Cancer
    Bregni, Giacomo
    Rebuzzi, Sara E.
    Fornarini, Giuseppe
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14): : 1380 - 1381
  • [34] Emerging mechanisms of enzalutamide resistance in prostate cancer
    Frank Claessens
    Christine Helsen
    Stefan Prekovic
    Thomas Van den Broeck
    Lien Spans
    Hendrik Van Poppel
    Steven Joniau
    Nature Reviews Urology, 2014, 11 : 712 - 716
  • [35] The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer
    Iacovelli, Roberto
    Ciccarese, Chiara
    Bria, Emilio
    Romano, Mario
    Fantinel, Emanuela
    Bimbatti, Davide
    Muraglia, Alessandro
    Porcaro, Antonio Benito
    Siracusano, Salvatore
    Brunelli, Matteo
    Mazzarotto, Renzo
    Artibani, Walter
    Tortora, Giampaolo
    CLINICAL GENITOURINARY CANCER, 2018, 16 (03) : E645 - E653
  • [36] Metastatic Prostate Cancer: Enzalutamide is superior to Placebo
    Nuhn, Philipp
    AKTUELLE UROLOGIE, 2018, 49 (05) : 381 - 382
  • [37] Enzalutamide in castration-resistant prostate cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2014, 15 (08): : E312 - E312
  • [38] The best fit for enzalutamide in metastatic prostate cancer
    Sumanta K. Pal
    Oliver Sartor
    Nature Reviews Clinical Oncology, 2014, 11 : 504 - 506
  • [39] Mitophagy imparts enzalutamide resistance in prostate cancer
    Basu, Hirak S.
    Schrieber, Cynthia L.
    Sperger, Jamie M.
    Naundorf, Maryanne
    Weichman, Ashley M.
    Mehraein-Ghomi, Farideh
    Church, Dawn R.
    Lang, Joshua M.
    Wilding, George
    CANCER RESEARCH, 2015, 75
  • [40] Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer
    Zoran Culig
    Current Molecular Biology Reports, 2017, 3 (4) : 230 - 235
12345